Table 2.
Baseline characteristics of participants.
| Victims N = 31,235 |
Non-victims N = 4,968,894 |
p value | |
|---|---|---|---|
| Male sex, n(%) | 13,583(43.5) | 2,304,674(46.4) | <.01 |
| Age group, n(%) | <.01 | ||
| 20–39 years | 4,654(14.9) | 1,302,881(26.2) | |
| 40–59 years | 7,741(24.8) | 1,513,019(30.5) | |
| 60–79 years | 13,681(43.8) | 1,540,583(31.0) | |
| 80- years | 5,159(16.5) | 612,411(12.3) | |
| Antidepressant user status, n(%) | <.01 | ||
| Non-user | 29,778(95.3) | 4,770,079(96.0) | |
| Continuous user | 1,457(4.7) | 198,815(4.0) | |
| Antidepressant prescriptions, n(%) | |||
| Tricyclic antidepressants | |||
| Pre disaster | 180(0.6) | 29,329(0.6) | .75 |
| Post disaster | 202(0.7) | 27,761(0.6) | .04 |
| Tetracyclic antidepressants | |||
| Pre disaster | 72(0.2) | 8,312(0.2) | .01 |
| Post disaster | 79(0.3) | 7,908(0.2) | <.01 |
| SSRIs | |||
| Pre disaster | 675(2.2) | 91,327(1.8) | <.01 |
| Post disaster | 740(2.4) | 89,950(1.8) | <.01 |
| SNRIs | |||
| Pre disaster | 448(1.4) | 56,368(1.1) | <.01 |
| Post disaster | 595(1.9) | 61,957(1.3) | <.01 |
| NaSSAs | |||
| Pre disaster | 154(0.5) | 24,902(0.5) | .84 |
| Post disaster | 255(0.8) | 25,279(0.5) | <.01 |
| SARIs | |||
| Pre disaster | 198(0.6) | 29,465(0.6) | .35 |
| Post disaster | 336(1.1) | 34,474(0.7) | <.01 |
| Total | |||
| Pre disaster | 1,457(4.7) | 198,815(4.0) | <.01 |
| Post disaster | 1,847(5.9) | 206,405(4.2) | <.01 |
Abbreviations: SSRIs = Selective Serotonin Reuptake Inhibitor, SNRIs = Serotonin-Norepinephrine Reuptake Inhibitors, NaSSAs = Noradrenergic and Specific Serotonergic Antidepressants, SARIs = Serotonin Antagonist and Reuptake Inhibitors.